When a cannabis testing company with three labs wanted to expand their operations, they faced a daunting challenge. The federal ban on interstate marijuana shipments meant they must open their own labs in each state, requiring a lot of time and money. But that wasn’t their only option. Instead, they […]
Big Med Device companies are facing a big problem – their buy to grow strategy isn’t working anymore. The can’t find enough small companies with new med tech in the market that aren’t extremely overpriced. Now big med device companies are looking at creating partnerships with earlier stage med device companies. Although it’s riskier, it’s the only way they can fill their big product pipelines. And that spells big licensing opportunities for startup and emerging med device companies.